We are live on ! Find out more
NC

NinePointTwo Capital Portfolio holdings

AUM $252M
1-Year Est. Return 12.98%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+12.98%
3 Year Est. Return
+1.62%
5 Year Est. Return
10 Year Est. Return
AUM
$370M
AUM Growth
+$59.2M
Cap. Flow
+$72.7M
Cap. Flow %
19.67%
Top 10 Hldgs %
78.35%
Holding
263
New
71
Increased
22
Reduced
3
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 6.24%
2 Healthcare 5.66%
3 Financials 3.87%
4 Consumer Discretionary 1.94%
5 Industrials 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSEC icon
201
Prospect Capital
PSEC
$1.06B
$119K 0.03%
14,410
-5,052
-26% -$42.1K
FOSL icon
202
Fossil Group
FOSL
$239M
$118K 0.03%
12,257
TDAY
203
USA Today Co
TDAY
$1.23B
$94K 0.03%
20,936
DBD
204
DELISTED
Diebold Nixdorf Incorporated
DBD
$92K 0.02%
13,802
IEF icon
205
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$88K 0.02%
827
QNCX icon
206
Quince Therapeutics
QNCX
$17.5M
$79K 0.02%
+64
New +$87.1K
AMTI
207
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$75K 0.02%
+10,091
New +$83.6K
NUVB icon
208
Nuvation Bio
NUVB
$2.24B
$74K 0.02%
14,115
DHX icon
209
DHI Group
DHX
$166M
$61K 0.02%
+10,284
New +$58.9K
IWM icon
210
iShares Russell 2000 ETF
IWM
$80.9B
$59K 0.02%
291
HYG icon
211
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$55K 0.01%
670
STTK icon
212
Shattuck Labs
STTK
$710M
$52K 0.01%
+12,387
New +$70.3K
CUE icon
213
Cue Biopharma
CUE
$135M
$51K 0.01%
+353
New +$74.9K
PASG icon
214
Passage Bio
PASG
$15.9M
$49K 0.01%
+806
New +$66.4K
DTIL icon
215
Precision BioSciences
DTIL
$188M
$41K 0.01%
+448
New +$60.9K
ANNX icon
216
Annexon
ANNX
$855M
$34K 0.01%
+12,717
New +$78.3K
VB icon
217
Vanguard Small-Cap ETF
VB
$79.5B
$24K 0.01%
114
EDU icon
218
New Oriental
EDU
$7.84B
$12K ﹤0.01%
1,074
IEMG icon
219
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$10K ﹤0.01%
187
ACN icon
220
Accenture
ACN
$89.9B
-507
Closed -$210K
ALNY icon
221
Alnylam Pharmaceuticals
ALNY
$36.3B
-1,672
Closed -$283K
ALT icon
222
Altimmune
ALT
$539M
-37,168
Closed -$340K
AMWL icon
223
American Well
AMWL
$181M
-2,213
Closed -$267K
AORT icon
224
Artivion
AORT
$1.23B
-12,257
Closed -$249K
ATER icon
225
Aterian
ATER
$4.35M
-3,260
Closed -$160K

Similar funds

NinePointTwo Capital's Q1 2022 Portfolio in Review

As of Q1 2022, NinePointTwo Capital held 263 positions worth $370M, up 19% from $311M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

NinePointTwo Capital deployed $72.7M of net new capital in Q1 2022, opening 71 new positions and adding to 22 existing holdings. Its largest new stake was Kodiak Sciences: 61,870 shares worth $477K.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares JPMorgan EM Local Currency Bond ETF, an estimated $256K trimmed.

  • NinePointTwo Capital's largest Q1 2022 buy was Kodiak Sciences: 61,870 shares worth $477K.
  • NinePointTwo Capital added most to Schwab US TIPS ETF in Q1 2022, an estimated $22.8M increase.
  • NinePointTwo Capital's biggest Q1 2022 reduction was iShares JPMorgan EM Local Currency Bond ETF, cutting an estimated $256K.
  • NinePointTwo Capital fully exited Olympic Steel in Q1 2022, selling an estimated $347K.
  • NinePointTwo Capital's ten largest holdings make up 78% of its $370M portfolio in Q1 2022.
  • NinePointTwo Capital opened 71 new positions and closed 44 in Q1 2022.
  • NinePointTwo Capital's portfolio value rose 19% quarter-over-quarter to $370M.

Based on NinePointTwo Capital's 13F filing for Q1 2022, filed 16 May 2022.